Extremely thin endometrial lining is a leading cause of implantation failure and may not respond to standard treatment in some women. Endometrial lining can be enhanced with the use of stem cell treatment in such circumstances.
The most common form of Stem Cell Therapy is a bone marrow transplant, although there are additional treatments based on umbilical cord blood.
Neurodegenerative disorders and conditions, including diabetes and heart disease, are among those being studied in an effort to identify new sources for stem cells and apply stem cell therapies.
When a patient's implantation fails because of a thin endometrium despite conventional treatment, stem cell therapy may be an option.